子宫内膜癌合并子宫肌瘤疾病的临床病理分析

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical pathological characteristics of endometrial carcinoma combined with uterine fibroids.Methods From August 2015 to December 2016,60 patients with endometrial carcinoma combined with uterine fibroids treated in our hospital were selected as group A.Another batch of 60 patients with endometrial carcinoma was randomly selected as group B for research analysis.The tumor histological grades,surgical pathological stages,progesterone receptor(PR),estrogen receptor(ER),ascites cytology,pathological type,and lymph node metastasis were compared and analyzed in both groups.Results The pathological stage of group B was significantly higher than that of group A (P<0.05).The tumor pathological grading in the group A was significantly lower than that in the group B with the characteristics of shallow muscle infiltration and high tissue differentiation.After surgery,the positivity rates of PR and ER in the group A were 61.7%and 78.3%.In the group B,the rates were 23.3%and 41.7%respectively.There were significant differences between the two groups (P<0.05).No significant difference in lymph node metastasis,ascites cytology,or pathological types was displayed between the two groups(P＞0.05).Conclusion Compared with endometrial carcinoma alone，combination of endometrial carcinoma and uterine fibroids has lower histological stage and tumor pathological grading,shallower muscle infiltration,better tissue differentiation,and higher positivity rates of PR and ER.

Key words： Endometrial carcinoma Uterine fibroids Pathology

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YANG Ju-ping
	ZOU Qin

Cite this article:

YANG Ju-ping,ZOU Qin. Clinical pathological analysis of endometrial carcinoma combined with uterine fibroids[J]. 中国当代医药, 2018, 25(20): 104-106.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I20/104

[1]	万颜凯，花秀英.41例子宫肌瘤患者子宫内膜病理特征分析[J].当代医学，2013，19（9）：68-69.
[2]	刘福军，凌斌，梁静，等.腹腔镜子宫肌瘤手术发现子宫恶性肿瘤15例的临床分析[J].中日友好医院学报，2017，31（5）：270-273.
[3]	沈长久.子宫内膜癌合并子宫肌瘤临床病理探讨[J]实用妇科内分泌电子杂志，2017，4（26）：56.
[4]	孙莉，梁磊.子宫肌瘤患者子宫内膜病理类型与其临床病理特征的关系[J].山东医药，2016，56（32）：92-93.
[5]	张静，于翠革，王爱玲，等.绝经前子宫内膜癌208例临床分析[J].陕西医学杂志，2016，45（2）：177-178.
[6]	夏红蕾，贾渊雯，李晓萍.子宫内膜癌合并子宫腺肌病1例[J].甘肃医药，2016，35（8）：633-634.
[7]	朱蒙蒙，赵丹鹤，叶洪娟，等.子宫肌瘤危险因素病例对照Logistic 回归分析[J].中国妇幼保健，2015，30（25）：4302-4304.
[8]	宁杰.子宫肌瘤患者的子宫内膜病理特征分析[J].中国医药科学，2017，7（20）：101-103.
[9]	邓俊祥.年轻妇女子宫内膜癌的超声诊断特点及临床价值分析[J].现代诊断与治疗，2014，25（8）：1871-1872.
[10]	傅亚均，曾雪影，王以容，等.血清3项检测对子宫肌瘤合并子宫内膜癌患者的术前诊断价值[J].检验医学与临床，2014，11（6）：809-810.
[11]	刘宋宋，张虹，杨超.子宫内膜癌合并子宫肌瘤或（和）子宫腺肌病临床病理分析[J].国际妇产科学杂志，2013，40（2）：187-190.
[12]	张窗竹，陈克敏，刘林祥.子宫内膜癌的MRI研究进展[J].放射学实践，2014，29（1）：97-99.
[13]	张永兵，洪宇.全子宫切除术后标本中子宫腺肌病与子宫内膜癌的关系研究[J].当代医学，2013，19（29）：25-26.
[14]	牛建清，陈兴伟，糜若然.子宫肌瘤发病因素的流行病学调查[J].国际妇产科学杂志，2013，40（1）：40-43.
[15]	张兰，余进进.子宫肌瘤发病的相关危险因素Logistic回归分析[J].东南大学学报（医学版），2012，31（2）：213-216.
[16]	余晓茹，郑飞云，杨孝军.子宫内膜癌合并子宫内膜异位症或子宫肌瘤的临床分析[J].武汉大学学报（医学版），2008，31（6）：816-818.
[17]	冯静，王建六，崔恒，等.子宫肌瘤患者的子宫内膜病理特征分析[J].实用妇产科杂志，2006，22（9）：561-563.